Vext Science (FRA:VV5) Other Current Assets: €1.02 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VV5 Vext Science Inc FRA:VV5
67 GF Score
Price €0.14
GF Value €0.94
! 3 Warning Signs
View Full Analysis

What is Vext Science Other Current Assets?

Vext Science FRA:VV5 67 Other Current Assets is €1.02 Mil as of Mar. 2026. GuruFocus rates FRA:VV5 with a GF Score™ of 67/100 and a GF Value™ of €0.94. The stock has 3 warning signs investors should review.

Vext Science's other current assets for the quarter that ended in Mar. 2026 was €1.02 Mil.

Vext Science's quarterly other current assets increased from Sep. 2025 (€1.29 Mil) to Dec. 2025 (€1.42 Mil) but then declined from Dec. 2025 (€1.42 Mil) to Mar. 2026 (€1.02Mil).

Vext Science's annual other current assets declined from Dec. 2023 (€5.51 Mil) to Dec. 2024 (€1.01 Mil) increased from Dec. 2024 (€1.01 Mil) to Dec. 2025 (€1.42 Mil).


Vext Science Other Current Assets Related Terms


Vext Science Other Current Assets Historical Data

* Premium members only.

The historical data trend for Vext Science's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vext Science Other Current Assets Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Assets
Get a 7-Day Free Trial Premium Member Only 0.26 9.39 5.51 1.01 1.42

Vext Science Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.15 1.22 1.29 1.42 1.02
FRA:VV5
67GF Score
Vext Science Inc FRA:VV5
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vext Science Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of €1.02 Mil mean?
Vext Science (FRA:VV5) has a Other Current Assets of €1.02 Mil as of Mar. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Vext Science.
Is Vext Science's Other Current Assets too high?
Vext Science's current Other Current Assets is €1.02 Mil. Overall, Vext Science has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Vext Science's Other Current Assets compare to ZTS?
Vext Science's Other Current Assets of €1.02 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Drug Manufacturers company?
A good Other Current Assets depends on the Drug Manufacturers industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Vext Science. Vext Science's current Other Current Assets is €1.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vext Science stock overvalued right now?
Vext Science (FRA:VV5) has a current Other Current Assets of €1.02 Mil. The stock's GF Value™ is €0.94, compared to a current price of €0.14 — trading 84.8% below its estimated fair value. The current Other Current Assets is €1.02 Mil. Vext Science's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Vext Science (FRA:VV5), the current Other Current Assets is €1.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vext Science (FRA:VV5) Overvalued in 2026?

Based on GuruFocus' analysis, Vext Science stock appears to be undervalued. The current stock price of €0.14 is trading 84.8% below its estimated GF Value™ of €0.94.

Key valuation signals for FRA:VV5:

  • Other Current Assets: €1.02 Mil
  • GF Value™: €0.94 vs. price of €0.14 (84.8% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the FRA:VV5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vext Science Business Description

Other Exchanges VEXTF:USAVEXT:Canada
Address 4152 N. 39th Avenue, Admin, Phoenix, AZ, USA, 85019
Vext Science Inc engages in the full spectrum of the cannabis product lifecycle, from development and manufacturing to distribution. Its brands include Herbal Wellness, Appalachian Pharm, Revibe, Prism, Vapen, and Firebrand. In Arizona and Ohio, the dispensaries operate under the Herbal Wellness Center brand, while in Ohio the cultivation and manufacturing operations are licensed and branded as Appalachian Pharms Cultivation and Appalachian Pharm Processing. The Company operates through a single operating segment engaged in the cultivation, manufacturing, distribution, and sale of cannabis within the United States. All revenues are generated in the United States.
67GF Score

Get the complete analysis for FRA:VV5

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price
€0.94
GF Value